CEL-SCI Corp share price logo

CEL-SCI Corp

NYSE: CVM

Small Cap

$2.28

-0.79

(-25.73%)

as on

CEL-SCI Corp Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.25
    $2.90
    downward going graph

    1.32%

    Downside

    27.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.98
    $13.48
    downward going graph

    13.16%

    Downside

    491.09%

    Upside

    downward going graph

CEL-SCI Corp share price movements today

Previous Close
$3.07
Open
$2.83
Volume
1.4M
Day's Low - High
$2.25 - $2.90
52 Week Low - High
$1.98 - $13.48

CEL-SCI Corp Historical Returns

1 Month Return
-34.29 %
3 Month Return
-54.49 %
1 Year Return
-69.72 %
3 Year Return
-96.81 %
5 Year Return
-99.66 %

CEL-SCI Corp Stock Fundamentals & Key Indicators

Check CEL-SCI Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.3M

EPS (TTM)

-4.16

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

1.1158

EBITDA

-21.2M

Revenue (TTM)

28.6K

Profit Margin

0.00%

Return On Equity TTM

-212.12%

CEL-SCI Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CEL-SCI Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
CEL-SCI Corp image
CEL-SCI Corp
BUY$19.3M-99.66%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.5B125.06%74.5912.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.8B97.31%27.7132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA118.975.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B44.57%17.1229.65%

Stock Returns calculator for CEL-SCI Corp Stock including INR - Dollar returns

The CEL-SCI Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

CEL-SCI Corp investment value today

Current value as on today

₹34,148

Returns

-₹65,852

(-65.85%)

Returns from CEL-SCI Corp Stock

-₹69,721 (-69.72%)

Dollar Impact

₹3,870 (+3.87%)

Analyst Recommendation on CEL-SCI Corp Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for CEL-SCI Corp. Average target price of $25

CEL-SCI Corp Share Price Target

Get share price movements and forecasts by analysts on CEL-SCI Corp.

What analysts predicted

90.88%UPSIDE

Target Price

$25

Current Price

$2.28

Analyzed by

5 Analysts

Target

$25.00

CEL-SCI Corp target price $25, a slight upside of 90.88% compared to current price of $2.28. According to 5 analysts rating.

CEL-SCI Corp Stock’s Investor Sentiment and Interest

Search interest for CEL-SCI Corp Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

CEL-SCI Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
5
-
-
-
-
Gross Profit
0
-1
0
0
-
0
0
0
0
0
Operating Income
-7
-6
-7
-6
-6
-6
-6
-5
-6
-5
EBITDA
-6
-5
-6
-5
-
-5
-5
-4
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
1
0
0
0
0
0
0
0
0
Income Before Tax
-7
-6
-7
-6
-6
-7
-6
-5
-6
-5
Income Tax Expense
0
0
0
0
-
0
-
-
-
-
Net Income
-7
-6
-7
-6
-6
-7
-6
-5
-6
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-118.81%
0.00%
0.00%
0.00%
0.00%

CEL-SCI Corp Annual Profit & Loss

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
0
0
0
0
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
-3
-3
-3
-3
Operating Income
-25
-21
-16
-20
-28
-36
-36
-31
-26
-24
EBITDA
-9
-9
-16
-19
-27
-34
-31
-27
-22
-20
Interest Expense
-
4
-
1
1
1
1
0
0
0
Depreciation
-
0
0
0
2
2
3
3
3
3
Income Before Tax
-11
-14
-31
-22
-30
-36
-36
-32
-26
-25
Income Tax Expense
-14
-6
-15
2
1
2
1
0
-
-
Net Income
-11
-14
-31
-24
-32
-39
-38
-32
-26
-25
Net Profit Margin
-4022.56%
-20810.33%
-6680.68%
-5336.04%
-5767.93%
0.00%
0.00%
0.00%
0.00%
0.00%

CEL-SCI Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-7
-6
-26
-7
-6
-5
-6
-5
Operating Cash Flow
-4
-4
-4
-18
-4
-4
-3
-4
-4
Investing Cash Flow
0
-
0
0
0
0
0
0
-
Financing Cash Flow
4
6
0
19
4
1
3
13
0
Change in Cash
0
2
-4
0
0
-2
0
9
-4

CEL-SCI Corp Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-14
-31
-22
-30
-36
-36
-32
-26
-25,411
Operating Cash Flow
-13
-13
-16
-15
-18
-18
-22
-18
-17,119
Investing Cash Flow
0
0
0
-2
-15
5
0
0
-38
Financing Cash Flow
13
21
14
25
54
0
4
19
23,373
Change in Cash
0
7
-1
7
20
-13
-18
0
6,215

Insights on CEL-SCI Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 85.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, CEL-SCI Corp has experienced a drawdown of -96.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 89.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CVM stock has moved down by -30.1%

About CEL-SCI Corp

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
OrganisationCEL-SCI Corp
Headquarters8229 Boone Boulevard, Vienna, VA, United States, 22182
IndustryBiotechnology
CEOMr. Geert R. Kersten Esq.
E-voting on sharesClick here to vote

Key Management of CEL-SCI Corp

Name

Title

Mr. Geert R. Kersten Esq.

Chief Executive & Financial Officer, CAO,Treasurer and Director

Ms. Patricia B. Prichep

Chief Financial & Operations Officer, Compliance Officer & Corporate Secretary

Dr. Eyal Talor Ph.D.

Chief Scientific Officer

Mr. John Cipriano

Senior Vice President of Regulatory Affairs

FAQs

What is CEL-SCI Corp share price today?

CEL-SCI Corp share price today is $2.28 as on at the close of the market. CEL-SCI Corp share today touched a day high of $2.9 and a low of $2.25.

What is the 52 week high and 52 week low for CEL-SCI Corp share?

CEL-SCI Corp share touched a 52 week high of $13.48 on and a 52 week low of $1.98 on . CEL-SCI Corp stock price today i.e. is closed at $2.28,which is 83.08% down from its 52 week high and 15.15% up from its 52 week low.

What is CEL-SCI Corp's market capitalisation today?

CEL-SCI Corp market capitalisation is $0.00T as on .

How to invest in CEL-SCI Corp Stock (CVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CEL-SCI Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CEL-SCI Corp Shares that will get you 0.6579 shares as per CEL-SCI Corp share price of $2.28 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy CEL-SCI Corp Stock (CVM) from India?

Indian investors can start investing in CEL-SCI Corp (CVM) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in CEL-SCI Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on CEL-SCI Corp share’s latest price of $2.28 as on May 2, 2026 at 1:29 am IST, you will get 4.3860 shares of CEL-SCI Corp. Learn more about fractional shares .

What are the returns that CEL-SCI Corp has given to Indian investors in the last 5 years?

CEL-SCI Corp stock has given -99.66% share price returns and 28.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?